BOI:EPA
Boiron USA
19,05 €
0,00%
(0,00) 1D
12-ноя., 17:35:20 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOI...
Mkt. cap
335,95 млн
Avg. vol.
4,88 миң
Volume
0,00
P/E ratio
12,63
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 миң
Mkt. cap
335,95 млн
Avg. vol.
4,88 миң
Volume
0,00
P/E ratio
12,63
52-wk high
32,25 €
52-wk low
16,90 €
EPS
1,51 €
Shares outstanding
17,55 млн
No. of employees
3 миң
News stories
From web sources and news partners
TradingView
·
1 саат мурун
Stock Market: Will S&P 500 Open Up or Down Today?
TradingView
·
1 саат мурун
SPX: S&P 500 Futures Edge Higher After Nvidia Crisis, 10-Year Yield Hits 5.14%
marketscreener.com
·
2 саат мурун
S&P 500 index fell after the Stockholm market closed Thursday
BeInCrypto
·
11 саат мурун
S&P 500 Recovered $1 Trillion in 90 Minutes Despite Wider Market Crash
Profile
Boiron is a manufacturer of homeopathic products, headquartered in France and with an operating presence in 59 countries worldwide. It is the largest manufacturer of homeopathic products in the world. In 2004, it had a workforce of 2,779 and turnover of € 313 million. It is a member of the CAC Small stock index.
In June 2005, the firm acquired Dolisos Laboratories, then the world's second largest manufacturer of homeopathic preparations.
Products of Boiron include mono- and poly-preparations, which Boiron refer to as "proprietary drugs".
Homeopathy is a pseudoscience with no evidence of effectiveness for stated claims or plausible mechanism of medicinal effect, and several class action lawsuits have been filed on behalf of consumers claiming that Boiron's homeopathic products, including Children's Coldcalm and Oscillococcinum, are useless and Boiron's marketing of these products is deceptive. Wikipedia
About Boiron USA
CEO-
Employees2,62 миң
Founded1932-ж., 7-июн.
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteboiron.fr